| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Galectin Therapeutics Inc (GALT) has 14 insiders with recent SEC Form 4 filings, including 10 buys and 2 sells. GALT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 10.33M | $21.70M | - | |
| 10% | 5.61M | $11.79M | - | |
| CFO | 100.0K | $210.0K | - | |
| CEO | 100.0K | $210.0K | - | |
| Other | 100.0K | $210.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 10, 2019 | 10x Fund, L.P.85 | 10% Owner | Sell | 17,000 | $3.73 | $63,325.00 | -0.3% | |
| Sep 6, 2019 | Freeman Kevin D56 | Director | Buy | 1,290 | $3.71 | $4,785.90 | +13.3% | |
| Sep 5, 2019 | Amelio Gilbert F | Director | Sell | 30,000 | $3.30 | $99,000.00 | -19.4% | |
| May 31, 2019 | Freeman Kevin D56 | Director | Buy | 9,136 | $4.28 | $39,102.08 | +38.0% | |
| May 31, 2019 | Lewis Joel | Director | Buy | 12,849 | $4.28 | $54,993.72 | +19.5% | |
| May 31, 2019 | Eldred Kary80 | Director | Buy | 3,033 | $4.28 | $12,981.24 | +7.3% | |
| May 31, 2019 | Callicutt Jack W62 | Chief Financial Officer | Buy | 2,354 | $4.28 | $10,075.12 | +186.8% | |
| May 31, 2019 | Omenn Gilbert S | Director | Buy | 18,578 | $4.28 | $79,513.84 | +38.6% | |
| May 31, 2019 | Uihlein Richard E | Director, 10% Owner | Buy | 4,680,606 | $4.28 | $20,032,993.68 | +148.7% | |
| Apr 9, 2019 | Uihlein Richard E | Director, 10% Owner | Buy | 20,700 | $4.82 | $99,850.59 | +0.8% |